| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |